Head and Neck Cancer Clinical Trials in Chongqing
2 recruitingChongqing, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Colorectal, CancerHead and Neck CancerNon-small Cell Lung Cancer+1 more
Betta Pharmaceuticals Co., Ltd.400 enrolled87 locationsNCT04930432
Recruiting
Noninvasive Intratumor Heterogeneity Evaluation in HNSCC
Head and Neck Cancer
First Affiliated Hospital of Chongqing Medical University700 enrolled1 locationNCT07027280